Global Rare Diseases Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Specialty Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Route of Administration, By Therapeutic Area, By Regional Outlook and Forecast, 2022 - 2028

The Global Rare Diseases Treatment Market size is expected to reach $255.4 billion by 2028, rising at a market growth of 12.5% CAGR during the forecast period.

A rare disease is one that impacts a small proportion of the population. In some parts of the world, an orphan disease is a rare disease that lacks a large enough market to gain support & resources for uncovering treatments for it, unless the government grants economically advantageous conditions for developing and selling such treatments. Rare disease treatments are those that have been created or sold for this purpose.

A multidisciplinary approach based on innovative initiatives for the development of novel SMA drugs to address unmet needs in rare disease treatment would surge the demand for rare diseases treatment. In addition, basic research on patient access, clinical development challenges, and regulatory approval processes are major characteristics highlighted in policy proposals.

The condition frequently affects a patient's entire family, and continuous care is taxing. Even if only a small number of people are affected by a disease, it can put a massively disproportionate strain on healthcare & social services. The value chain can be extended to achieve forward integration. To achieve a high return on investment, operating efficiency is being increased. This can be accomplished by shifting the production of important medicines to orphan drugs.

COVID-19 Impact Analysis

The ongoing COVID-19 pandemic is a major public health concern that has presented numerous challenges to researchers, healthcare providers, and patients. Because of the risk of coronavirus exposure, R&D organizations and biopharma companies are not able to concentrate on the development of new treatments. To address such challenges, the FDA is proactively collaborating with manufacturers to provide advanced treatments to maintain health care continuity by focusing on ongoing clinical trials. As a result, during the pandemic period, drugs for rare disease treatments are all being developed in a very limited quantity and thus limiting the market growth for rare disease treatments in the upcoming years.

Market Growth Factors

The increasing presence of rare diseases

Because of the high prevalence of individuals suffering from rare diseases, special drugs will be required, which is accelerating the acceptance of rare disease treatments. These treatments are aimed at specific genes that have been transformed in order to cure the disease. Because of their simplicity and major non-invasive treatments, these treatments have grown in popularity. With this rise in popularity, rare disease treatment is expected to expand rapidly. Furthermore, these treatments are becoming more popular as healthcare infrastructure around the world improves.

Rising R&D initiative for rare diseases treatment

The increasing R&D investments by popular vendors for orphan drug development of novel product offerings is one of the crucial driving factors prevailing in the market. Because public awareness and understanding of rare diseases have grown, a large number of key clinical-stage biopharmaceutical companies and established market players now have orphan drug pipeline candidates in various stages of clinical trials. This growing interest in rare disorder therapeutics is due to the fact that major pharmaceutical breakthroughs resulting in blockbuster drug developments are more likely in rare disorders than in traditional pharmaceutical portfolios.

Market Restraining Factors

High costs involved in R&D of the rare diseases treatment

Despite the increased focus on the development and marketing of rare disease therapeutics around the world, certain constraints are limiting the market growth. The high cost of researching and developing pipeline candidates for the treatment of rare diseases leads to an increase in drug prices. This huge cost of treatments has seriously limited the wide adoption of these product lines, particularly in developing countries. Such high treatment costs are also a source of concern in developed countries, where many drugs might not be adequately paid back, and hence, significantly increasing the patient's out-of-pocket costs.

Drug Type outlook

By drug type, the rare disease treatment market is divided into biologics, biosimilar, and small molecule. The small molecule segment generated a substantial revenue share in the rare diseases treatment market in 2021. One of the factors influencing the demand for small molecule drugs is the small and medium-sized pharmaceutical companies' increasing demand for outsourcing. Also, the strict regulations on the development, manufacturing & quality control are further supporting the market growth in this segment.

Distribution Channel Outlook

Based on distribution channel, the rare diseases treatment market is classified into hospital pharmacy, specialty pharmacy and online pharmacy. In 2021, the specialty segment witnessed the largest revenue share in the rare diseases treatment market. The growth is attributed to major players' strategic initiatives, like the acquisition of specialty pharmacies for the distribution of their drugs. During the forecast period, such mergers are anticipated to boost segment growth. Specialty drugs are extremely sophisticated drugs, usually based on biology, which structurally resemble substances found in the body.

Route of Administration Outlook

On the basis of route of administration, the rare disease treatment market is fragmented into oral, injectable and others. The oral segment covered a significant revenue share in the rare disease treatment market in 2021. The market share is due to several benefits such as safety, compliance, ease of ingestion, and no risk of pain in the oral route of administration. As a result of growing awareness about the efficacy of such drugs, the oral route of administration has become more popular in the treatment of rare diseases.

Therapeutic Area Outlook

Based on therapeutic area, the rare disease treatment market is segmented into cancer, neurological conditions, cardiovascular conditions, musculoskeletal conditions, hematologic disorders, infectious diseases, metabolic disorders, endocrine disorders and others. In 2021, the cancer segment dominated the rare disease treatment market by generating the highest revenue share. The high prevalence & recurrence rate of rare cancer evidence is the major factor responsible for this dominance. In addition, new treatments are continuously being updated for curing patients suffering from rare cancers.

Rare Diseases Treatment Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 115.4 Billion
Market size forecast in 2028	USD 255.4 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 12.5% from 2022 to 2028
Number of Pages	308
Number of Tables	503
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Drug Type, Distribution Channel, Route of Administration, Therapeutic Area, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	The increasing presence of rare diseases Rising R&D initiative for rare diseases treatment
Restraints	High costs involved in R&D of the rare diseases treatment

Regional Outlook

Region wise, the rare disease treatment market is analyzed across the North America, Europe, Asia Pacific and LAMEA. In 2021, the North America region dominated the rare diseases treatment market with the maximum revenue share. This is because of the high prevalence of diseases, favorable healthcare infrastructure, and new product approvals for treatment. Access to products may enhance patient compliance, thereby expanding the customer base in the nations such as Canada, and the United States are propelling the growth of rare disease treatment in the North America region.

Free Valuable Insights: Global Rare Diseases Treatment Market size to reach USD 255.4 Billion by 2028

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Merck Group, Bristol Myers Squibb Company, Pfizer, Inc., AstraZeneca PLC, Takeda Pharmaceutical Company Limited and PTC Therapeutics, Inc.

Strategies deployed in Rare Diseases Treatment Market

» Partnerships, Collaborations and Mergers:

• Jul-2022: PTC Therapeutics partnered with Saphetor, a global precision medicine company. The partnership would be centred around supporting awareness of clinical programs for rare diseases. With this partnership, PTC would look forward to leveraging Saphetor’s new approach to bring together the global genomics community to build awareness of the rare disease programs.
• Jun-2022: Pfizer partnered with Sirana Pharma, a biotechnology company. The partnership would help Pfizer in investigating the potential identification & validation of a novel treatment concept for rare and debilitating bone diseases. Furthermore, the acquisition would initially involve using Sirana’s proprietary microRNA approach, which targets substantial regenerative recovery of diseased muscle & bone tissue.
• Apr-2022: Takeda entered into a partnership with Centogene, the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases. Under this partnership, CENTOGENE would continue providing Takeda access to diagnostic testing for patients across the globe. This partnership would support the expansion of Takeda’s world-class enzyme replacement treatments & most essentially, bring real solutions to under-served patient communities.
• Mar-2022: AbbVie joins hands with Gedeon Richter, a Hungarian multinational pharmaceutical and biotechnology company. Under the collaboration, the company focused on research, develop & commercialization of novel dopamine receptor modulators for the potential treatment of neuropsychiatric diseases. Further, through the collaboration, the companies would continue to build on the research that seeks to provide additional insights into the understanding of cariprazine's clinical pharmacology and explore novel chemistry to identify innovative dopamine receptor modulators.
• Dec-2021: AstraZeneca signed an agreement with Ionis Pharmaceuticals, a biotechnology company. Under this agreement, the companies would design and commercialize eplontersen also known as IONIS-TTR-LRX. This product is developed to reduce the production of transthyretin (TTR protein) to treat hereditary as well as non-hereditary forms of TTR amyloidosis (ATTR).
• Jul-2021: Pfizer teamed up with AbbVie, an American publicly traded Biopharmaceutical Company. Through the acquisition, Pfizer would carefully assess how biomedical data at this unprecedented scale is best utilized and hopefully accelerate the path from genetic discoveries to novel therapeutics.

» Acquisitions & Mergers

• Aug-2022: Pfizer signed an agreement to acquire GBT, a biopharmaceutical company. The acquisition would complement & improve Pfizer’s more than 30-year heritage in rare hematology and reinforce the company’s commitment to SCD by bringing expertise and a leading portfolio and pipeline with the potential to address the full spectrum of critical requirements in this underserved community.
• Jun-2022: Pfizer took over ReViral, a privately held, clinical-stage Biopharmaceutical Company. The acquisition would demonstrate the company's commitment to advancing pioneering science both through in-house expertise as well as work with leading, innovative companies with the goal of delivering innovative breakthroughs to patients suffering from serious infectious diseases.
• May-2022: Pfizer signed an agreement to acquire Biohaven Pharmaceutical Holding Company, a clinical-stage biopharmaceutical company. Through this acquisition, Pfizer would be exceptionally positioned to help the portfolio reach its full potential given the company's leading scale & capabilities that includes comprehensive field force engagement with Primary Care Physicians, specialists, and health systems delivering the right information at the right time.
• Jun-2022: PTC Therapeutics completed the acquisition of Censa Pharmaceuticals, a biopharmaceutical company developing CNSA-001 (sepiapterin), a clinical-stage investigational therapy for orphan metabolic diseases. The acquisition would add a well-established late-stage PKU clinical program to the increased rare disease portfolio.
• Dec-2021: Merck signed an agreement to acquire Chord Therapeutics, a Swiss-based biotech company. By this acquisition, Merck aimed at leveraging its existing capabilities to further develop an oral cladribine product tailored particularly for MS, oncologic disorders, gMG, and NMOSD.
• Sep-2021: Merck took over Acceleron Pharma, an American clinical-stage biopharmaceutical company. The company aimed at broadening its portfolio beyond the aging cancer drug Keytruda with potential treatments that could bring in fresh revenue. The acquisition would enable Merck to access Acceleron’s rare disease drug candidate, sotatercept, which the company would expect to be a multi-billion-dollar peak sales opportunity, and would come as Keytruda moves toward the loss of market exclusivity in 2028.
• Jul-2021: AstraZeneca took over Alexion Pharmaceuticals, a global biopharmaceutical company. Through this acquisition, the company would be able to enter into medicines for rare diseases and the beginning of a new chapter. Further, the acquisition improved AstraZeneca's scientific presence in immunology and, through Alexion’s new complement-biology platform and robust pipeline, would continue to pioneer the discovery & development of medicines for patients with rare diseases.

» Approvals and Trials:

• Apr-2022: Novartis got FDA approval for Vijoice, a kinase inhibitor that treats rare overgrowth conditions. Vijoice would be the first FDA-approved treatment for PROS, a spectrum of rare conditions characterized by overgrowths & blood vessel anomalies impacting an estimated 14 people per million. The approval would support the treatment of adult & paediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who need systemic therapy.

Scope of the Study

Market Segments Covered in the Report:

By Drug Type

• Biologics
• Biosimilar
• Small Molecule

By Distribution Channel

• Specialty Pharmacy
• Hospital Pharmacy
• Online Pharmacy

By Route of Administration

• Injectable
• Oral
• Others

By Therapeutic Area

• Cancer
• Cardiovascular Conditions
• Infectious Diseases
• Musculoskeletal Conditions
• Endocrine Disorders
• Metabolic Disorders
• Hematologic Disorders
• Neurological Conditions
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• AbbVie, Inc.
• F. Hoffmann-La Roche Ltd.
• Bayer AG
• Novartis AG
• Merck Group
• Bristol Myers Squibb Company
• Pfizer, Inc.
• AstraZeneca PLC
• Takeda Pharmaceutical Company Limited
• PTC Therapeutics, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Rare Diseases Treatment Market, by Drug Type
1.4.2 Global Rare Diseases Treatment Market, by Distribution Channel
1.4.3 Global Rare Diseases Treatment Market, by Route of Administration
1.4.4 Global Rare Diseases Treatment Market, by Therapeutic Area
1.4.5 Global Rare Diseases Treatment Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisition and Mergers
3.2.3 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Aug) Leading Players

Chapter 4. Global Rare Diseases Treatment Market by Drug Type
4.1 Global Biologics Market by Region
4.2 Global Biosimilar Market by Region
4.3 Global Small Molecule Market by Region

Chapter 5. Global Rare Diseases Treatment Market by Distribution Channel
5.1 Global Specialty Pharmacy Market by Region
5.2 Global Hospital Pharmacy Market by Region
5.3 Global Online Pharmacy Market by Region

Chapter 6. Global Rare Diseases Treatment Market by Route of Administration
6.1 Global Injectable Market by Region
6.2 Global Oral Market by Region
6.3 Global Others Market by Region

Chapter 7. Global Rare Diseases Treatment Market by Therapeutic Area
7.1 Global Cancer Market by Region
7.2 Global Cardiovascular Conditions Market by Region
7.3 Global Infectious Diseases Market by Region
7.4 Global Musculoskeletal Conditions Market by Region
7.5 Global Endocrine Disorders Market by Region
7.6 Global Metabolic Disorders Market by Region
7.7 Global Hematologic Disorders Market by Region
7.8 Global Neurological Conditions Market by Region
7.9 Global Others Market by Region

Chapter 8. Global Rare Diseases Treatment Market by Region
8.1 North America Rare Diseases Treatment Market
8.1.1 North America Rare Diseases Treatment Market by Drug Type
8.1.1.1 North America Biologics Market by Country
8.1.1.2 North America Biosimilar Market by Country
8.1.1.3 North America Small Molecule Market by Country
8.1.2 North America Rare Diseases Treatment Market by Distribution Channel
8.1.2.1 North America Specialty Pharmacy Market by Country
8.1.2.2 North America Hospital Pharmacy Market by Country
8.1.2.3 North America Online Pharmacy Market by Country
8.1.3 North America Rare Diseases Treatment Market by Route of Administration
8.1.3.1 North America Injectable Market by Country
8.1.3.2 North America Oral Market by Country
8.1.3.3 North America Others Market by Country
8.1.4 North America Rare Diseases Treatment Market by Therapeutic Area
8.1.4.1 North America Cancer Market by Country
8.1.4.2 North America Cardiovascular Conditions Market by Country
8.1.4.3 North America Infectious Diseases Market by Country
8.1.4.4 North America Musculoskeletal Conditions Market by Country
8.1.4.5 North America Endocrine Disorders Market by Country
8.1.4.6 North America Metabolic Disorders Market by Country
8.1.4.7 North America Hematologic Disorders Market by Country
8.1.4.8 North America Neurological Conditions Market by Country
8.1.4.9 North America Others Market by Country
8.1.5 North America Rare Diseases Treatment Market by Country
8.1.5.1 US Rare Diseases Treatment Market
8.1.5.1.1 US Rare Diseases Treatment Market by Drug Type
8.1.5.1.2 US Rare Diseases Treatment Market by Distribution Channel
8.1.5.1.3 US Rare Diseases Treatment Market by Route of Administration
8.1.5.1.4 US Rare Diseases Treatment Market by Therapeutic Area
8.1.5.2 Canada Rare Diseases Treatment Market
8.1.5.2.1 Canada Rare Diseases Treatment Market by Drug Type
8.1.5.2.2 Canada Rare Diseases Treatment Market by Distribution Channel
8.1.5.2.3 Canada Rare Diseases Treatment Market by Route of Administration
8.1.5.2.4 Canada Rare Diseases Treatment Market by Therapeutic Area
8.1.5.3 Mexico Rare Diseases Treatment Market
8.1.5.3.1 Mexico Rare Diseases Treatment Market by Drug Type
8.1.5.3.2 Mexico Rare Diseases Treatment Market by Distribution Channel
8.1.5.3.3 Mexico Rare Diseases Treatment Market by Route of Administration
8.1.5.3.4 Mexico Rare Diseases Treatment Market by Therapeutic Area
8.1.5.4 Rest of North America Rare Diseases Treatment Market
8.1.5.4.1 Rest of North America Rare Diseases Treatment Market by Drug Type
8.1.5.4.2 Rest of North America Rare Diseases Treatment Market by Distribution Channel
8.1.5.4.3 Rest of North America Rare Diseases Treatment Market by Route of Administration
8.1.5.4.4 Rest of North America Rare Diseases Treatment Market by Therapeutic Area
8.2 Europe Rare Diseases Treatment Market
8.2.1 Europe Rare Diseases Treatment Market by Drug Type
8.2.1.1 Europe Biologics Market by Country
8.2.1.2 Europe Biosimilar Market by Country
8.2.1.3 Europe Small Molecule Market by Country
8.2.2 Europe Rare Diseases Treatment Market by Distribution Channel
8.2.2.1 Europe Specialty Pharmacy Market by Country
8.2.2.2 Europe Hospital Pharmacy Market by Country
8.2.2.3 Europe Online Pharmacy Market by Country
8.2.3 Europe Rare Diseases Treatment Market by Route of Administration
8.2.3.1 Europe Injectable Market by Country
8.2.3.2 Europe Oral Market by Country
8.2.3.3 Europe Others Market by Country
8.2.4 Europe Rare Diseases Treatment Market by Therapeutic Area
8.2.4.1 Europe Cancer Market by Country
8.2.4.2 Europe Cardiovascular Conditions Market by Country
8.2.4.3 Europe Infectious Diseases Market by Country
8.2.4.4 Europe Musculoskeletal Conditions Market by Country
8.2.4.5 Europe Endocrine Disorders Market by Country
8.2.4.6 Europe Metabolic Disorders Market by Country
8.2.4.7 Europe Hematologic Disorders Market by Country
8.2.4.8 Europe Neurological Conditions Market by Country
8.2.4.9 Europe Others Market by Country
8.2.5 Europe Rare Diseases Treatment Market by Country
8.2.5.1 Germany Rare Diseases Treatment Market
8.2.5.1.1 Germany Rare Diseases Treatment Market by Drug Type
8.2.5.1.2 Germany Rare Diseases Treatment Market by Distribution Channel
8.2.5.1.3 Germany Rare Diseases Treatment Market by Route of Administration
8.2.5.1.4 Germany Rare Diseases Treatment Market by Therapeutic Area
8.2.5.2 UK Rare Diseases Treatment Market
8.2.5.2.1 UK Rare Diseases Treatment Market by Drug Type
8.2.5.2.2 UK Rare Diseases Treatment Market by Distribution Channel
8.2.5.2.3 UK Rare Diseases Treatment Market by Route of Administration
8.2.5.2.4 UK Rare Diseases Treatment Market by Therapeutic Area
8.2.5.3 France Rare Diseases Treatment Market
8.2.5.3.1 France Rare Diseases Treatment Market by Drug Type
8.2.5.3.2 France Rare Diseases Treatment Market by Distribution Channel
8.2.5.3.3 France Rare Diseases Treatment Market by Route of Administration
8.2.5.3.4 France Rare Diseases Treatment Market by Therapeutic Area
8.2.5.4 Russia Rare Diseases Treatment Market
8.2.5.4.1 Russia Rare Diseases Treatment Market by Drug Type
8.2.5.4.2 Russia Rare Diseases Treatment Market by Distribution Channel
8.2.5.4.3 Russia Rare Diseases Treatment Market by Route of Administration
8.2.5.4.4 Russia Rare Diseases Treatment Market by Therapeutic Area
8.2.5.5 Spain Rare Diseases Treatment Market
8.2.5.5.1 Spain Rare Diseases Treatment Market by Drug Type
8.2.5.5.2 Spain Rare Diseases Treatment Market by Distribution Channel
8.2.5.5.3 Spain Rare Diseases Treatment Market by Route of Administration
8.2.5.5.4 Spain Rare Diseases Treatment Market by Therapeutic Area
8.2.5.6 Italy Rare Diseases Treatment Market
8.2.5.6.1 Italy Rare Diseases Treatment Market by Drug Type
8.2.5.6.2 Italy Rare Diseases Treatment Market by Distribution Channel
8.2.5.6.3 Italy Rare Diseases Treatment Market by Route of Administration
8.2.5.6.4 Italy Rare Diseases Treatment Market by Therapeutic Area
8.2.5.7 Rest of Europe Rare Diseases Treatment Market
8.2.5.7.1 Rest of Europe Rare Diseases Treatment Market by Drug Type
8.2.5.7.2 Rest of Europe Rare Diseases Treatment Market by Distribution Channel
8.2.5.7.3 Rest of Europe Rare Diseases Treatment Market by Route of Administration
8.2.5.7.4 Rest of Europe Rare Diseases Treatment Market by Therapeutic Area
8.3 Asia Pacific Rare Diseases Treatment Market
8.3.1 Asia Pacific Rare Diseases Treatment Market by Drug Type
8.3.1.1 Asia Pacific Biologics Market by Country
8.3.1.2 Asia Pacific Biosimilar Market by Country
8.3.1.3 Asia Pacific Small Molecule Market by Country
8.3.2 Asia Pacific Rare Diseases Treatment Market by Distribution Channel
8.3.2.1 Asia Pacific Specialty Pharmacy Market by Country
8.3.2.2 Asia Pacific Hospital Pharmacy Market by Country
8.3.2.3 Asia Pacific Online Pharmacy Market by Country
8.3.3 Asia Pacific Rare Diseases Treatment Market by Route of Administration
8.3.3.1 Asia Pacific Injectable Market by Country
8.3.3.2 Asia Pacific Oral Market by Country
8.3.3.3 Asia Pacific Others Market by Country
8.3.4 Asia Pacific Rare Diseases Treatment Market by Therapeutic Area
8.3.4.1 Asia Pacific Cancer Market by Country
8.3.4.2 Asia Pacific Cardiovascular Conditions Market by Country
8.3.4.3 Asia Pacific Infectious Diseases Market by Country
8.3.4.4 Asia Pacific Musculoskeletal Conditions Market by Country
8.3.4.5 Asia Pacific Endocrine Disorders Market by Country
8.3.4.6 Asia Pacific Metabolic Disorders Market by Country
8.3.4.7 Asia Pacific Hematologic Disorders Market by Country
8.3.4.8 Asia Pacific Neurological Conditions Market by Country
8.3.4.9 Asia Pacific Others Market by Country
8.3.5 Asia Pacific Rare Diseases Treatment Market by Country
8.3.5.1 China Rare Diseases Treatment Market
8.3.5.1.1 China Rare Diseases Treatment Market by Drug Type
8.3.5.1.2 China Rare Diseases Treatment Market by Distribution Channel
8.3.5.1.3 China Rare Diseases Treatment Market by Route of Administration
8.3.5.1.4 China Rare Diseases Treatment Market by Therapeutic Area
8.3.5.2 Japan Rare Diseases Treatment Market
8.3.5.2.1 Japan Rare Diseases Treatment Market by Drug Type
8.3.5.2.2 Japan Rare Diseases Treatment Market by Distribution Channel
8.3.5.2.3 Japan Rare Diseases Treatment Market by Route of Administration
8.3.5.2.4 Japan Rare Diseases Treatment Market by Therapeutic Area
8.3.5.3 India Rare Diseases Treatment Market
8.3.5.3.1 India Rare Diseases Treatment Market by Drug Type
8.3.5.3.2 India Rare Diseases Treatment Market by Distribution Channel
8.3.5.3.3 India Rare Diseases Treatment Market by Route of Administration
8.3.5.3.4 India Rare Diseases Treatment Market by Therapeutic Area
8.3.5.4 South Korea Rare Diseases Treatment Market
8.3.5.4.1 South Korea Rare Diseases Treatment Market by Drug Type
8.3.5.4.2 South Korea Rare Diseases Treatment Market by Distribution Channel
8.3.5.4.3 South Korea Rare Diseases Treatment Market by Route of Administration
8.3.5.4.4 South Korea Rare Diseases Treatment Market by Therapeutic Area
8.3.5.5 Singapore Rare Diseases Treatment Market
8.3.5.5.1 Singapore Rare Diseases Treatment Market by Drug Type
8.3.5.5.2 Singapore Rare Diseases Treatment Market by Distribution Channel
8.3.5.5.3 Singapore Rare Diseases Treatment Market by Route of Administration
8.3.5.5.4 Singapore Rare Diseases Treatment Market by Therapeutic Area
8.3.5.6 Malaysia Rare Diseases Treatment Market
8.3.5.6.1 Malaysia Rare Diseases Treatment Market by Drug Type
8.3.5.6.2 Malaysia Rare Diseases Treatment Market by Distribution Channel
8.3.5.6.3 Malaysia Rare Diseases Treatment Market by Route of Administration
8.3.5.6.4 Malaysia Rare Diseases Treatment Market by Therapeutic Area
8.3.5.7 Rest of Asia Pacific Rare Diseases Treatment Market
8.3.5.7.1 Rest of Asia Pacific Rare Diseases Treatment Market by Drug Type
8.3.5.7.2 Rest of Asia Pacific Rare Diseases Treatment Market by Distribution Channel
8.3.5.7.3 Rest of Asia Pacific Rare Diseases Treatment Market by Route of Administration
8.3.5.7.4 Rest of Asia Pacific Rare Diseases Treatment Market by Therapeutic Area
8.4 LAMEA Rare Diseases Treatment Market
8.4.1 LAMEA Rare Diseases Treatment Market by Drug Type
8.4.1.1 LAMEA Biologics Market by Country
8.4.1.2 LAMEA Biosimilar Market by Country
8.4.1.3 LAMEA Small Molecule Market by Country
8.4.2 LAMEA Rare Diseases Treatment Market by Distribution Channel
8.4.2.1 LAMEA Specialty Pharmacy Market by Country
8.4.2.2 LAMEA Hospital Pharmacy Market by Country
8.4.2.3 LAMEA Online Pharmacy Market by Country
8.4.3 LAMEA Rare Diseases Treatment Market by Route of Administration
8.4.3.1 LAMEA Injectable Market by Country
8.4.3.2 LAMEA Oral Market by Country
8.4.3.3 LAMEA Others Market by Country
8.4.4 LAMEA Rare Diseases Treatment Market by Therapeutic Area
8.4.4.1 LAMEA Cancer Market by Country
8.4.4.2 LAMEA Cardiovascular Conditions Market by Country
8.4.4.3 LAMEA Infectious Diseases Market by Country
8.4.4.4 LAMEA Musculoskeletal Conditions Market by Country
8.4.4.5 LAMEA Endocrine Disorders Market by Country
8.4.4.6 LAMEA Metabolic Disorders Market by Country
8.4.4.7 LAMEA Hematologic Disorders Market by Country
8.4.4.8 LAMEA Neurological Conditions Market by Country
8.4.4.9 LAMEA Others Market by Country
8.4.5 LAMEA Rare Diseases Treatment Market by Country
8.4.5.1 Brazil Rare Diseases Treatment Market
8.4.5.1.1 Brazil Rare Diseases Treatment Market by Drug Type
8.4.5.1.2 Brazil Rare Diseases Treatment Market by Distribution Channel
8.4.5.1.3 Brazil Rare Diseases Treatment Market by Route of Administration
8.4.5.1.4 Brazil Rare Diseases Treatment Market by Therapeutic Area
8.4.5.2 Argentina Rare Diseases Treatment Market
8.4.5.2.1 Argentina Rare Diseases Treatment Market by Drug Type
8.4.5.2.2 Argentina Rare Diseases Treatment Market by Distribution Channel
8.4.5.2.3 Argentina Rare Diseases Treatment Market by Route of Administration
8.4.5.2.4 Argentina Rare Diseases Treatment Market by Therapeutic Area
8.4.5.3 UAE Rare Diseases Treatment Market
8.4.5.3.1 UAE Rare Diseases Treatment Market by Drug Type
8.4.5.3.2 UAE Rare Diseases Treatment Market by Distribution Channel
8.4.5.3.3 UAE Rare Diseases Treatment Market by Route of Administration
8.4.5.3.4 UAE Rare Diseases Treatment Market by Therapeutic Area
8.4.5.4 Saudi Arabia Rare Diseases Treatment Market
8.4.5.4.1 Saudi Arabia Rare Diseases Treatment Market by Drug Type
8.4.5.4.2 Saudi Arabia Rare Diseases Treatment Market by Distribution Channel
8.4.5.4.3 Saudi Arabia Rare Diseases Treatment Market by Route of Administration
8.4.5.4.4 Saudi Arabia Rare Diseases Treatment Market by Therapeutic Area
8.4.5.5 South Africa Rare Diseases Treatment Market
8.4.5.5.1 South Africa Rare Diseases Treatment Market by Drug Type
8.4.5.5.2 South Africa Rare Diseases Treatment Market by Distribution Channel
8.4.5.5.3 South Africa Rare Diseases Treatment Market by Route of Administration
8.4.5.5.4 South Africa Rare Diseases Treatment Market by Therapeutic Area
8.4.5.6 Nigeria Rare Diseases Treatment Market
8.4.5.6.1 Nigeria Rare Diseases Treatment Market by Drug Type
8.4.5.6.2 Nigeria Rare Diseases Treatment Market by Distribution Channel
8.4.5.6.3 Nigeria Rare Diseases Treatment Market by Route of Administration
8.4.5.6.4 Nigeria Rare Diseases Treatment Market by Therapeutic Area
8.4.5.7 Rest of LAMEA Rare Diseases Treatment Market
8.4.5.7.1 Rest of LAMEA Rare Diseases Treatment Market by Drug Type
8.4.5.7.2 Rest of LAMEA Rare Diseases Treatment Market by Distribution Channel
8.4.5.7.3 Rest of LAMEA Rare Diseases Treatment Market by Route of Administration
8.4.5.7.4 Rest of LAMEA Rare Diseases Treatment Market by Therapeutic Area

Chapter 9. Company Profiles
9.1 AbbVie, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.3 Bayer AG
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Novartis AG
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Approval and Trails:
9.5 Merck Group
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.6 Bristol Myers Squibb Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Acquisition and Mergers:
9.7 Pfizer, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional & Segmental Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Acquisitions and Mergers:
9.8 AstraZeneca PLC
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Acquisition and Mergers:
9.9 Takeda Pharmaceutical Company Limited
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Acquisition and Mergers:
9.10. PTC Therapeutics, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:
9.10.5.2 Acquisition and Mergers:

TABLE 1 Global Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 2 Global Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Rare Disease Treatment Market
TABLE 4 Acquisition and Mergers – Rare Disease Treatment Market
TABLE 5 Approvals and Trials – Rare Disease Treatment Market
TABLE 6 Global Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 7 Global Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 8 Global Biologics Market by Region, 2018 - 2021, USD Million
TABLE 9 Global Biologics Market by Region, 2022 - 2028, USD Million
TABLE 10 Global Biosimilar Market by Region, 2018 - 2021, USD Million
TABLE 11 Global Biosimilar Market by Region, 2022 - 2028, USD Million
TABLE 12 Global Small Molecule Market by Region, 2018 - 2021, USD Million
TABLE 13 Global Small Molecule Market by Region, 2022 - 2028, USD Million
TABLE 14 Global Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 15 Global Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 16 Global Specialty Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 17 Global Specialty Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 18 Global Hospital Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 19 Global Hospital Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 20 Global Online Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 21 Global Online Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 22 Global Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 23 Global Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 24 Global Injectable Market by Region, 2018 - 2021, USD Million
TABLE 25 Global Injectable Market by Region, 2022 - 2028, USD Million
TABLE 26 Global Oral Market by Region, 2018 - 2021, USD Million
TABLE 27 Global Oral Market by Region, 2022 - 2028, USD Million
TABLE 28 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 29 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 30 Global Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 31 Global Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 32 Global Cancer Market by Region, 2018 - 2021, USD Million
TABLE 33 Global Cancer Market by Region, 2022 - 2028, USD Million
TABLE 34 Global Cardiovascular Conditions Market by Region, 2018 - 2021, USD Million
TABLE 35 Global Cardiovascular Conditions Market by Region, 2022 - 2028, USD Million
TABLE 36 Global Infectious Diseases Market by Region, 2018 - 2021, USD Million
TABLE 37 Global Infectious Diseases Market by Region, 2022 - 2028, USD Million
TABLE 38 Global Musculoskeletal Conditions Market by Region, 2018 - 2021, USD Million
TABLE 39 Global Musculoskeletal Conditions Market by Region, 2022 - 2028, USD Million
TABLE 40 Global Endocrine Disorders Market by Region, 2018 - 2021, USD Million
TABLE 41 Global Endocrine Disorders Market by Region, 2022 - 2028, USD Million
TABLE 42 Global Metabolic Disorders Market by Region, 2018 - 2021, USD Million
TABLE 43 Global Metabolic Disorders Market by Region, 2022 - 2028, USD Million
TABLE 44 Global Hematologic Disorders Market by Region, 2018 - 2021, USD Million
TABLE 45 Global Hematologic Disorders Market by Region, 2022 - 2028, USD Million
TABLE 46 Global Neurological Conditions Market by Region, 2018 - 2021, USD Million
TABLE 47 Global Neurological Conditions Market by Region, 2022 - 2028, USD Million
TABLE 48 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 49 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 50 Global Rare Diseases Treatment Market by Region, 2018 - 2021, USD Million
TABLE 51 Global Rare Diseases Treatment Market by Region, 2022 - 2028, USD Million
TABLE 52 North America Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 53 North America Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 54 North America Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 55 North America Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 56 North America Biologics Market by Country, 2018 - 2021, USD Million
TABLE 57 North America Biologics Market by Country, 2022 - 2028, USD Million
TABLE 58 North America Biosimilar Market by Country, 2018 - 2021, USD Million
TABLE 59 North America Biosimilar Market by Country, 2022 - 2028, USD Million
TABLE 60 North America Small Molecule Market by Country, 2018 - 2021, USD Million
TABLE 61 North America Small Molecule Market by Country, 2022 - 2028, USD Million
TABLE 62 North America Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 63 North America Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 64 North America Specialty Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 65 North America Specialty Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 66 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 67 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 68 North America Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 69 North America Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 70 North America Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 71 North America Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 72 North America Injectable Market by Country, 2018 - 2021, USD Million
TABLE 73 North America Injectable Market by Country, 2022 - 2028, USD Million
TABLE 74 North America Oral Market by Country, 2018 - 2021, USD Million
TABLE 75 North America Oral Market by Country, 2022 - 2028, USD Million
TABLE 76 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 77 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 78 North America Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 79 North America Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 80 North America Cancer Market by Country, 2018 - 2021, USD Million
TABLE 81 North America Cancer Market by Country, 2022 - 2028, USD Million
TABLE 82 North America Cardiovascular Conditions Market by Country, 2018 - 2021, USD Million
TABLE 83 North America Cardiovascular Conditions Market by Country, 2022 - 2028, USD Million
TABLE 84 North America Infectious Diseases Market by Country, 2018 - 2021, USD Million
TABLE 85 North America Infectious Diseases Market by Country, 2022 - 2028, USD Million
TABLE 86 North America Musculoskeletal Conditions Market by Country, 2018 - 2021, USD Million
TABLE 87 North America Musculoskeletal Conditions Market by Country, 2022 - 2028, USD Million
TABLE 88 North America Endocrine Disorders Market by Country, 2018 - 2021, USD Million
TABLE 89 North America Endocrine Disorders Market by Country, 2022 - 2028, USD Million
TABLE 90 North America Metabolic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 91 North America Metabolic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 92 North America Hematologic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 93 North America Hematologic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 94 North America Neurological Conditions Market by Country, 2018 - 2021, USD Million
TABLE 95 North America Neurological Conditions Market by Country, 2022 - 2028, USD Million
TABLE 96 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 97 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 98 North America Rare Diseases Treatment Market by Country, 2018 - 2021, USD Million
TABLE 99 North America Rare Diseases Treatment Market by Country, 2022 - 2028, USD Million
TABLE 100 US Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 101 US Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 102 US Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 103 US Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 104 US Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 105 US Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 106 US Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 107 US Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 108 US Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 109 US Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 110 Canada Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 111 Canada Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 112 Canada Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 113 Canada Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 114 Canada Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 115 Canada Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 116 Canada Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 117 Canada Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 118 Canada Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 119 Canada Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 120 Mexico Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 121 Mexico Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 122 Mexico Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 123 Mexico Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 124 Mexico Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 125 Mexico Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 126 Mexico Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 127 Mexico Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 128 Mexico Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 129 Mexico Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 130 Rest of North America Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 131 Rest of North America Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 132 Rest of North America Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 133 Rest of North America Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 134 Rest of North America Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 135 Rest of North America Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 136 Rest of North America Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 137 Rest of North America Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 138 Rest of North America Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 139 Rest of North America Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 140 Europe Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 141 Europe Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 142 Europe Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 143 Europe Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 144 Europe Biologics Market by Country, 2018 - 2021, USD Million
TABLE 145 Europe Biologics Market by Country, 2022 - 2028, USD Million
TABLE 146 Europe Biosimilar Market by Country, 2018 - 2021, USD Million
TABLE 147 Europe Biosimilar Market by Country, 2022 - 2028, USD Million
TABLE 148 Europe Small Molecule Market by Country, 2018 - 2021, USD Million
TABLE 149 Europe Small Molecule Market by Country, 2022 - 2028, USD Million
TABLE 150 Europe Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 151 Europe Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 152 Europe Specialty Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 153 Europe Specialty Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 154 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 155 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 156 Europe Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 157 Europe Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 158 Europe Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 159 Europe Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 160 Europe Injectable Market by Country, 2018 - 2021, USD Million
TABLE 161 Europe Injectable Market by Country, 2022 - 2028, USD Million
TABLE 162 Europe Oral Market by Country, 2018 - 2021, USD Million
TABLE 163 Europe Oral Market by Country, 2022 - 2028, USD Million
TABLE 164 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 165 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 166 Europe Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 167 Europe Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 168 Europe Cancer Market by Country, 2018 - 2021, USD Million
TABLE 169 Europe Cancer Market by Country, 2022 - 2028, USD Million
TABLE 170 Europe Cardiovascular Conditions Market by Country, 2018 - 2021, USD Million
TABLE 171 Europe Cardiovascular Conditions Market by Country, 2022 - 2028, USD Million
TABLE 172 Europe Infectious Diseases Market by Country, 2018 - 2021, USD Million
TABLE 173 Europe Infectious Diseases Market by Country, 2022 - 2028, USD Million
TABLE 174 Europe Musculoskeletal Conditions Market by Country, 2018 - 2021, USD Million
TABLE 175 Europe Musculoskeletal Conditions Market by Country, 2022 - 2028, USD Million
TABLE 176 Europe Endocrine Disorders Market by Country, 2018 - 2021, USD Million
TABLE 177 Europe Endocrine Disorders Market by Country, 2022 - 2028, USD Million
TABLE 178 Europe Metabolic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 179 Europe Metabolic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 180 Europe Hematologic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 181 Europe Hematologic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 182 Europe Neurological Conditions Market by Country, 2018 - 2021, USD Million
TABLE 183 Europe Neurological Conditions Market by Country, 2022 - 2028, USD Million
TABLE 184 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 185 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 186 Europe Rare Diseases Treatment Market by Country, 2018 - 2021, USD Million
TABLE 187 Europe Rare Diseases Treatment Market by Country, 2022 - 2028, USD Million
TABLE 188 Germany Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 189 Germany Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 190 Germany Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 191 Germany Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 192 Germany Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 193 Germany Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 194 Germany Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 195 Germany Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 196 Germany Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 197 Germany Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 198 UK Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 199 UK Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 200 UK Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 201 UK Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 202 UK Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 203 UK Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 204 UK Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 205 UK Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 206 UK Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 207 UK Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 208 France Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 209 France Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 210 France Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 211 France Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 212 France Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 213 France Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 214 France Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 215 France Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 216 France Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 217 France Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 218 Russia Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 219 Russia Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 220 Russia Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 221 Russia Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 222 Russia Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 223 Russia Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 224 Russia Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 225 Russia Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 226 Russia Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 227 Russia Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 228 Spain Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 229 Spain Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 230 Spain Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 231 Spain Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 232 Spain Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 233 Spain Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 234 Spain Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 235 Spain Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 236 Spain Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 237 Spain Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 238 Italy Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 239 Italy Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 240 Italy Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 241 Italy Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 242 Italy Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 243 Italy Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 244 Italy Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 245 Italy Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 246 Italy Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 247 Italy Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 248 Rest of Europe Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 249 Rest of Europe Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 250 Rest of Europe Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 251 Rest of Europe Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 252 Rest of Europe Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 253 Rest of Europe Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 254 Rest of Europe Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 255 Rest of Europe Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 256 Rest of Europe Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 257 Rest of Europe Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 258 Asia Pacific Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 259 Asia Pacific Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 260 Asia Pacific Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 261 Asia Pacific Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 262 Asia Pacific Biologics Market by Country, 2018 - 2021, USD Million
TABLE 263 Asia Pacific Biologics Market by Country, 2022 - 2028, USD Million
TABLE 264 Asia Pacific Biosimilar Market by Country, 2018 - 2021, USD Million
TABLE 265 Asia Pacific Biosimilar Market by Country, 2022 - 2028, USD Million
TABLE 266 Asia Pacific Small Molecule Market by Country, 2018 - 2021, USD Million
TABLE 267 Asia Pacific Small Molecule Market by Country, 2022 - 2028, USD Million
TABLE 268 Asia Pacific Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 269 Asia Pacific Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 270 Asia Pacific Specialty Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 271 Asia Pacific Specialty Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 272 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 273 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 274 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 275 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 276 Asia Pacific Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 277 Asia Pacific Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 278 Asia Pacific Injectable Market by Country, 2018 - 2021, USD Million
TABLE 279 Asia Pacific Injectable Market by Country, 2022 - 2028, USD Million
TABLE 280 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
TABLE 281 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
TABLE 282 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 283 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 284 Asia Pacific Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 285 Asia Pacific Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 286 Asia Pacific Cancer Market by Country, 2018 - 2021, USD Million
TABLE 287 Asia Pacific Cancer Market by Country, 2022 - 2028, USD Million
TABLE 288 Asia Pacific Cardiovascular Conditions Market by Country, 2018 - 2021, USD Million
TABLE 289 Asia Pacific Cardiovascular Conditions Market by Country, 2022 - 2028, USD Million
TABLE 290 Asia Pacific Infectious Diseases Market by Country, 2018 - 2021, USD Million
TABLE 291 Asia Pacific Infectious Diseases Market by Country, 2022 - 2028, USD Million
TABLE 292 Asia Pacific Musculoskeletal Conditions Market by Country, 2018 - 2021, USD Million
TABLE 293 Asia Pacific Musculoskeletal Conditions Market by Country, 2022 - 2028, USD Million
TABLE 294 Asia Pacific Endocrine Disorders Market by Country, 2018 - 2021, USD Million
TABLE 295 Asia Pacific Endocrine Disorders Market by Country, 2022 - 2028, USD Million
TABLE 296 Asia Pacific Metabolic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 297 Asia Pacific Metabolic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 298 Asia Pacific Hematologic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 299 Asia Pacific Hematologic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 300 Asia Pacific Neurological Conditions Market by Country, 2018 - 2021, USD Million
TABLE 301 Asia Pacific Neurological Conditions Market by Country, 2022 - 2028, USD Million
TABLE 302 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 303 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 304 Asia Pacific Rare Diseases Treatment Market by Country, 2018 - 2021, USD Million
TABLE 305 Asia Pacific Rare Diseases Treatment Market by Country, 2022 - 2028, USD Million
TABLE 306 China Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 307 China Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 308 China Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 309 China Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 310 China Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 311 China Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 312 China Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 313 China Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 314 China Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 315 China Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 316 Japan Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 317 Japan Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 318 Japan Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 319 Japan Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 320 Japan Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 321 Japan Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 322 Japan Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 323 Japan Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 324 Japan Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 325 Japan Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 326 India Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 327 India Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 328 India Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 329 India Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 330 India Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 331 India Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 332 India Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 333 India Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 334 India Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 335 India Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 336 South Korea Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 337 South Korea Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 338 South Korea Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 339 South Korea Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 340 South Korea Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 341 South Korea Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 342 South Korea Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 343 South Korea Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 344 South Korea Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 345 South Korea Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 346 Singapore Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 347 Singapore Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 348 Singapore Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 349 Singapore Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 350 Singapore Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 351 Singapore Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 352 Singapore Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 353 Singapore Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 354 Singapore Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 355 Singapore Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 356 Malaysia Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 357 Malaysia Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 358 Malaysia Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 359 Malaysia Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 360 Malaysia Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 361 Malaysia Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 362 Malaysia Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 363 Malaysia Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 364 Malaysia Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 365 Malaysia Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 366 Rest of Asia Pacific Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 367 Rest of Asia Pacific Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 368 Rest of Asia Pacific Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 369 Rest of Asia Pacific Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 370 Rest of Asia Pacific Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 371 Rest of Asia Pacific Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 372 Rest of Asia Pacific Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 373 Rest of Asia Pacific Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 374 Rest of Asia Pacific Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 375 Rest of Asia Pacific Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 376 LAMEA Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 377 LAMEA Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 378 LAMEA Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 379 LAMEA Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 380 LAMEA Biologics Market by Country, 2018 - 2021, USD Million
TABLE 381 LAMEA Biologics Market by Country, 2022 - 2028, USD Million
TABLE 382 LAMEA Biosimilar Market by Country, 2018 - 2021, USD Million
TABLE 383 LAMEA Biosimilar Market by Country, 2022 - 2028, USD Million
TABLE 384 LAMEA Small Molecule Market by Country, 2018 - 2021, USD Million
TABLE 385 LAMEA Small Molecule Market by Country, 2022 - 2028, USD Million
TABLE 386 LAMEA Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 387 LAMEA Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 388 LAMEA Specialty Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 389 LAMEA Specialty Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 390 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 391 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 392 LAMEA Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 393 LAMEA Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 394 LAMEA Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 395 LAMEA Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 396 LAMEA Injectable Market by Country, 2018 - 2021, USD Million
TABLE 397 LAMEA Injectable Market by Country, 2022 - 2028, USD Million
TABLE 398 LAMEA Oral Market by Country, 2018 - 2021, USD Million
TABLE 399 LAMEA Oral Market by Country, 2022 - 2028, USD Million
TABLE 400 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 401 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 402 LAMEA Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 403 LAMEA Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 404 LAMEA Cancer Market by Country, 2018 - 2021, USD Million
TABLE 405 LAMEA Cancer Market by Country, 2022 - 2028, USD Million
TABLE 406 LAMEA Cardiovascular Conditions Market by Country, 2018 - 2021, USD Million
TABLE 407 LAMEA Cardiovascular Conditions Market by Country, 2022 - 2028, USD Million
TABLE 408 LAMEA Infectious Diseases Market by Country, 2018 - 2021, USD Million
TABLE 409 LAMEA Infectious Diseases Market by Country, 2022 - 2028, USD Million
TABLE 410 LAMEA Musculoskeletal Conditions Market by Country, 2018 - 2021, USD Million
TABLE 411 LAMEA Musculoskeletal Conditions Market by Country, 2022 - 2028, USD Million
TABLE 412 LAMEA Endocrine Disorders Market by Country, 2018 - 2021, USD Million
TABLE 413 LAMEA Endocrine Disorders Market by Country, 2022 - 2028, USD Million
TABLE 414 LAMEA Metabolic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 415 LAMEA Metabolic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 416 LAMEA Hematologic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 417 LAMEA Hematologic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 418 LAMEA Neurological Conditions Market by Country, 2018 - 2021, USD Million
TABLE 419 LAMEA Neurological Conditions Market by Country, 2022 - 2028, USD Million
TABLE 420 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 421 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 422 LAMEA Rare Diseases Treatment Market by Country, 2018 - 2021, USD Million
TABLE 423 LAMEA Rare Diseases Treatment Market by Country, 2022 - 2028, USD Million
TABLE 424 Brazil Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 425 Brazil Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 426 Brazil Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 427 Brazil Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 428 Brazil Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 429 Brazil Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 430 Brazil Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 431 Brazil Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 432 Brazil Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 433 Brazil Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 434 Argentina Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 435 Argentina Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 436 Argentina Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 437 Argentina Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 438 Argentina Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 439 Argentina Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 440 Argentina Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 441 Argentina Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 442 Argentina Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 443 Argentina Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 444 UAE Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 445 UAE Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 446 UAE Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 447 UAE Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 448 UAE Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 449 UAE Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 450 UAE Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 451 UAE Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 452 UAE Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 453 UAE Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 454 Saudi Arabia Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 455 Saudi Arabia Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 456 Saudi Arabia Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 457 Saudi Arabia Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 458 Saudi Arabia Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 459 Saudi Arabia Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 460 Saudi Arabia Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 461 Saudi Arabia Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 462 Saudi Arabia Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 463 Saudi Arabia Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 464 South Africa Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 465 South Africa Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 466 South Africa Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 467 South Africa Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 468 South Africa Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 469 South Africa Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 470 South Africa Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 471 South Africa Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 472 South Africa Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 473 South Africa Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 474 Nigeria Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 475 Nigeria Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 476 Nigeria Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 477 Nigeria Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 478 Nigeria Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 479 Nigeria Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 480 Nigeria Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 481 Nigeria Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 482 Nigeria Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 483 Nigeria Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 484 Rest of LAMEA Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 485 Rest of LAMEA Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 486 Rest of LAMEA Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 487 Rest of LAMEA Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 488 Rest of LAMEA Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 489 Rest of LAMEA Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 490 Rest of LAMEA Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 491 Rest of LAMEA Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 492 Rest of LAMEA Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 493 Rest of LAMEA Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 494 Key information – AbbVie, Inc.
TABLE 495 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 496 Key Information – Bayer AG
TABLE 497 Key Information – Novartis AG
TABLE 498 key Information – Merck GrouP
TABLE 499 Key Information – Bristol Myers Squibb Company
TABLE 500 Key Information – Pfizer, Inc.
TABLE 501 KEY INFORMATION – ASTRAZENECA PLC
TABLE 502 Key Information – Takeda Pharmaceutical Company Limited
TABLE 503 Key Information – PTC Therapeutics, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Aug) Leading Players
FIG 5 Global Rare Diseases Treatment Market share by Drug Type, 2021
FIG 6 Global Rare Diseases Treatment Market share by Drug Type, 2028
FIG 7 Global Rare Diseases Treatment Market by Drug Type, 2018 - 2028, USD Million
FIG 8 Global Rare Diseases Treatment Market share by Distribution Channel, 2021
FIG 9 Global Rare Diseases Treatment Market share by Distribution Channel, 2028
FIG 10 Global Rare Diseases Treatment Market by Distribution Channel, 2018 - 2028, USD Million
FIG 11 Global Rare Diseases Treatment Market share by Route of Administration, 2021
FIG 12 Global Rare Diseases Treatment Market share by Route of Administration, 2028
FIG 13 Global Rare Diseases Treatment Market by Route of Administration, 2018 - 2028, USD Million
FIG 14 Global Rare Diseases Treatment Market share by Therapeutic Area, 2021
FIG 15 Global Rare Diseases Treatment Market share by Therapeutic Area, 2028
FIG 16 Global Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2028, USD Million
FIG 17 Global Rare Diseases Treatment Market share by Region, 2021
FIG 18 Global Rare Diseases Treatment Market share by Region, 2028
FIG 19 Global Rare Diseases Treatment Market by Region, 2018 - 2028, USD Million
FIG 20 Recent strategies and developments: Pfizer, Inc.
FIG 21 Recent strategies and developments: PTC Therapeutics, Inc.